A detailed history of Beacon Bridge Wealth Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beacon Bridge Wealth Partners, LLC holds 5,527 shares of BMY stock, worth $316,862. This represents 0.12% of its overall portfolio holdings.

Number of Shares
5,527
Previous 5,527 -0.0%
Holding current value
$316,862
Previous $230 Million 24.58%
% of portfolio
0.12%
Previous 0.11%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $378,488 - $448,184
5,527 New
5,527 $398 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Beacon Bridge Wealth Partners, LLC Portfolio

Follow Beacon Bridge Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Bridge Wealth Partners, LLC with notifications on news.